Review



pyrosequencing based analysis  (Pyrosequencing Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Pyrosequencing Inc pyrosequencing based analysis
    Pyrosequencing Based Analysis, supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pyrosequencing+based+assay/16s+pyrosequencing+rrna/pm42128334-658-12-12
    Average 86 stars, based on 1 article reviews
    pyrosequencing based analysis - by Bioz Stars, 2026-10
    86/100 stars

    Images

    Related Articles

    Mutagenesis:

    Article Title: Should Oncologists Be Aware in Their Clinical Practice of <i>KRAS</i> Molecular Analysis?
    Article Snippet: .. The detection limit of these two methods is around 20% of the mutation rate.6 The pyrosequencing-based assay detects KRAS mutations in codons 12, 13 and it is more sensitive than traditional sequencing methods or real-time PCR being able to detect mutation rate represented in fewer than 20% of the analyzed sample. ..

    Sequencing:

    Article Title: Should Oncologists Be Aware in Their Clinical Practice of <i>KRAS</i> Molecular Analysis?
    Article Snippet: .. The detection limit of these two methods is around 20% of the mutation rate.6 The pyrosequencing-based assay detects KRAS mutations in codons 12, 13 and it is more sensitive than traditional sequencing methods or real-time PCR being able to detect mutation rate represented in fewer than 20% of the analyzed sample. ..

    Real-time Polymerase Chain Reaction:

    Article Title: Should Oncologists Be Aware in Their Clinical Practice of <i>KRAS</i> Molecular Analysis?
    Article Snippet: .. The detection limit of these two methods is around 20% of the mutation rate.6 The pyrosequencing-based assay detects KRAS mutations in codons 12, 13 and it is more sensitive than traditional sequencing methods or real-time PCR being able to detect mutation rate represented in fewer than 20% of the analyzed sample. ..



    Similar Products

    pyrosequencing based analysis  (Pyrosequencing Inc)
    86
    Pyrosequencing Inc pyrosequencing based analysis
    Pyrosequencing Based Analysis, supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pyrosequencing+based+assay/16s+pyrosequencing+rrna/pm42128334-658-12-12
    Average 86 stars, based on 1 article reviews
    pyrosequencing based analysis - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    pyrosequencing based speid technology  (Pyrosequencing Inc)
    86
    Pyrosequencing Inc pyrosequencing based speid technology
    Pyrosequencing Based Speid Technology, supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pyrosequencing+based+assay/based+pyrosequencing+speid+technology/pmc12642167-178-13-13
    Average 86 stars, based on 1 article reviews
    pyrosequencing based speid technology - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    chip based pyrosequencing  (Pyrosequencing Inc)
    86
    Pyrosequencing Inc chip based pyrosequencing
    Chip Based Pyrosequencing, supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pyrosequencing+based+assay/based+chip+pyrosequencing/pm41187758-709-4-5
    Average 86 stars, based on 1 article reviews
    chip based pyrosequencing - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    pyrosequencing-based methylation analysis  (Pyrosequencing Inc)
    90
    Pyrosequencing Inc pyrosequencing-based methylation analysis
    Pyrosequencing Based Methylation Analysis, supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pyrosequencing+based+assay/pyrosequencing+based+methylation+analysis/pm40647502-43-0-0
    Average 90 stars, based on 1 article reviews
    pyrosequencing-based methylation analysis - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    bisulfite-based pyrosequencing  (Pyrosequencing Inc)
    90
    Pyrosequencing Inc bisulfite-based pyrosequencing
    Bisulfite Based Pyrosequencing, supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pyrosequencing+based+assay/bisulfite+pyrosequencing/pmc12054201-156-6-7
    Average 90 stars, based on 1 article reviews
    bisulfite-based pyrosequencing - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    pyrosequencing-based mgmtp methylation score  (Pyrosequencing Inc)
    90
    Pyrosequencing Inc pyrosequencing-based mgmtp methylation score
    Association between progression-free survival (PFS) and the <t>MGMTp</t> <t>methylation</t> score. The association of the MGMTp methylation score, based on the MGMT-STP27 procedure, with progression-free survival (PFS; interval from diagnosis) was evaluated by the hazard ratio (confidence interval at 95%) from the cox regression model. The forest plots in A and B correspond to the PFS reported for patients treated in EORTC-22033 with temozolomide (TMZ) or radiotherapy (RT), respectively. , The MGMT-STP27 score was significant in the TMZ treated patients, but not in the patients with RT. The forest plots in C and D visualize the outcome of the Montpellier patients treated with TMZ, with time to progression defined by the next treatment-free survival (NxtTrtFS), and PFS defined by RANO, respectively. The MGMT-STP27 score was significant in the Montpellier cohort when using NxtTrtFS as outcome measure, a trend was observed when using RANO criteria for PFS. * P <.05; ** P <.01.
    Pyrosequencing Based Mgmtp Methylation Score, supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pyrosequencing+based+assay/mgmtp+methylation+specific+pyrosequencing/pmc11877643-149-12-12
    Average 90 stars, based on 1 article reviews
    pyrosequencing-based mgmtp methylation score - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    16s rrna gene-based pyrosequencing surveys  (Pyrosequencing Inc)
    90
    Pyrosequencing Inc 16s rrna gene-based pyrosequencing surveys
    Association between progression-free survival (PFS) and the <t>MGMTp</t> <t>methylation</t> score. The association of the MGMTp methylation score, based on the MGMT-STP27 procedure, with progression-free survival (PFS; interval from diagnosis) was evaluated by the hazard ratio (confidence interval at 95%) from the cox regression model. The forest plots in A and B correspond to the PFS reported for patients treated in EORTC-22033 with temozolomide (TMZ) or radiotherapy (RT), respectively. , The MGMT-STP27 score was significant in the TMZ treated patients, but not in the patients with RT. The forest plots in C and D visualize the outcome of the Montpellier patients treated with TMZ, with time to progression defined by the next treatment-free survival (NxtTrtFS), and PFS defined by RANO, respectively. The MGMT-STP27 score was significant in the Montpellier cohort when using NxtTrtFS as outcome measure, a trend was observed when using RANO criteria for PFS. * P <.05; ** P <.01.
    16s Rrna Gene Based Pyrosequencing Surveys, supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pyrosequencing+based+assay/16s+rrna+pyrosequencing/pm39581029-104-10-13
    Average 90 stars, based on 1 article reviews
    16s rrna gene-based pyrosequencing surveys - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Association between progression-free survival (PFS) and the MGMTp methylation score. The association of the MGMTp methylation score, based on the MGMT-STP27 procedure, with progression-free survival (PFS; interval from diagnosis) was evaluated by the hazard ratio (confidence interval at 95%) from the cox regression model. The forest plots in A and B correspond to the PFS reported for patients treated in EORTC-22033 with temozolomide (TMZ) or radiotherapy (RT), respectively. , The MGMT-STP27 score was significant in the TMZ treated patients, but not in the patients with RT. The forest plots in C and D visualize the outcome of the Montpellier patients treated with TMZ, with time to progression defined by the next treatment-free survival (NxtTrtFS), and PFS defined by RANO, respectively. The MGMT-STP27 score was significant in the Montpellier cohort when using NxtTrtFS as outcome measure, a trend was observed when using RANO criteria for PFS. * P <.05; ** P <.01.

    Journal: Neuro-Oncology Advances

    Article Title: Clinical value of the MGMT promoter methylation score in IDHmt low-grade glioma for predicting benefit from temozolomide treatment

    doi: 10.1093/noajnl/vdae224

    Figure Lengend Snippet: Association between progression-free survival (PFS) and the MGMTp methylation score. The association of the MGMTp methylation score, based on the MGMT-STP27 procedure, with progression-free survival (PFS; interval from diagnosis) was evaluated by the hazard ratio (confidence interval at 95%) from the cox regression model. The forest plots in A and B correspond to the PFS reported for patients treated in EORTC-22033 with temozolomide (TMZ) or radiotherapy (RT), respectively. , The MGMT-STP27 score was significant in the TMZ treated patients, but not in the patients with RT. The forest plots in C and D visualize the outcome of the Montpellier patients treated with TMZ, with time to progression defined by the next treatment-free survival (NxtTrtFS), and PFS defined by RANO, respectively. The MGMT-STP27 score was significant in the Montpellier cohort when using NxtTrtFS as outcome measure, a trend was observed when using RANO criteria for PFS. * P <.05; ** P <.01.

    Article Snippet: The association between the MGMT-STP27 score and NxtTrtFS was confirmed using a pyrosequencing-based MGMTp methylation score (MGMT-PYROscore) obtained for the same samples ( P = .002, ).

    Techniques: Methylation, Biomarker Discovery